Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Total Current Liabilities (2016 - 2026)

Skinvisible's Total Current Liabilities history spans 16 years, with the latest figure at $5.0 million for Q4 2025.

  • On a quarterly basis, Total Current Liabilities rose 37.2% to $5.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 37.2% increase, with the full-year FY2025 number at $5.0 million, up 37.2% from a year prior.
  • Total Current Liabilities hit $5.0 million in Q4 2025 for Skinvisible, up from $4.8 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for SKVI hit a ceiling of $5.0 million in Q4 2025 and a floor of $2.7 million in Q1 2023.
  • Historically, Total Current Liabilities has averaged $3.7 million across 5 years, with a median of $3.6 million in 2022.
  • Biggest five-year swings in Total Current Liabilities: fell 12.62% in 2023 and later skyrocketed 50.18% in 2024.
  • Tracing SKVI's Total Current Liabilities over 5 years: stood at $3.1 million in 2021, then grew by 19.07% to $3.6 million in 2022, then decreased by 3.64% to $3.5 million in 2023, then rose by 4.12% to $3.7 million in 2024, then skyrocketed by 37.2% to $5.0 million in 2025.
  • Business Quant data shows Total Current Liabilities for SKVI at $5.0 million in Q4 2025, $4.8 million in Q3 2025, and $4.5 million in Q2 2025.